Share This Article:

Emergence of Optochin Resistance among Streptococcus pneumoniae in Japan

Full-Text HTML XML Download Download as PDF (Size:252KB) PP. 8-15
DOI: 10.4236/ojmm.2012.21002    3,759 Downloads   8,843 Views   Citations


The optochin susceptibility test is a key method for differentiating Streptococcus pneumoniae from other α-hemolytic streptococci; however, optochin-resistant (Optr) S. pneumoniae have been reported in the last two decades. In this study, we investigated the isolation frequency of Optr S. pneumoniae in the North Kyushu area of Japan, and biochemically and genetically characterized Optr S. pneumoniae clinical isolates. Seven (0.68%) out of 1032 S. pneumoniae isolates collected by the North Fukuoka Infectious Diseases Working Group were found to be Optr S. pneumoniae. Resistant strains had MICs of optochin 2- to 64- fold higher than susceptible strains, possessed different antimicrobial resistance profiles, and belonged to different serotypes. All the seven Optr isolates had mutations in the nucleotide sequence code for subunit c of F0F1 ATPase. Three isolates had mutations in codon 48 (deduced amino acid substitution of valine with phenylalanine) and two isolates had mutations in codon 49 (substitution of alanine with threonine or serine). Of the remaining two isolates, one had mutation in codon 50 (substitution of phenylalanine with leucine) and the other had mutation in codon 44 (substitution of methionine with isoleucine, which was a novel mutation in this position). From these results, we identified the mutation in the H+-ATPase subunit c gene (atpC) of S. pneumoniae, which was not recognized earlier, and determined that Opt resistance among Japanese pneumococcal isolates is not related to a specific pneumococcal serotype or antimicrobial resistance profile. Furthermore, the results indicate that when α-hemolytic streptococci resistant to optochin are isolated from patients with invasive infectious diseases, such as meningitis and pneumonia, we should perform additional examinations such as bile solubility tests or PCR assays before confirming isolates as viridans streptococci. This is the first report of the characterization of Optr S. pneumoniae in Japan.

Cite this paper

M. Nagata, O. Ueda, T. Shobuike, T. Muratani, Y. Aoki and H. Miyamoto, "Emergence of Optochin Resistance among Streptococcus pneumoniae in Japan," Open Journal of Medical Microbiology, Vol. 2 No. 1, 2012, pp. 8-15. doi: 10.4236/ojmm.2012.21002.


[1] D. A Musher, “Streptococcus pneumoniae,” In: G. L. Mandell, J. E. Bennett and R. Dolin, Eds., Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases, 6th Edition, Churchill Livingstone, Philadelphia, 2005, pp. 2392-2411.
[2] K. P. Klugman, “Pneumococcal Resistance to Antibiotics,” Clinical Microbiology Reviews, Vol. 3, No. 2, 1990, p. 171.
[3] K. Z. Rochs, “Zur Differentialdiagnose der Streptokokken und Pneumokokken,” Virchows Archiv, Vol. 220, No. 3, 1915, pp. 327-346. dio:10.1007/BF01949112
[4] E. F. Bowers and L. R. Jeffries, “Optochin in the Identification of Streptococcus pneumoniae,” Journal of Clinical Pathology. Vol. 8, 1955, pp. 58-60. dio:10.1136/jcp.8.1.58
[5] S. Kontiainen and A. Sivonen, “Optochin Resistance in Streptococcus pneumoniae Strains Isolated from Blood and Middle Ear Fluid,” European Journal of Clinical Microbiology, Vol. 6, No. 4, 1987, pp. 422-424. dio:10.1007/BF02013101
[6] A. P. Borek, D. C. Dressel, J. Hussong and L. R. Peterson, “Evolving Clinical Problems with Streptococcus pneumoniae: Increasing Resistance to Antimicrobial Agents, and Failure of Traditional Optochin Identification in Chicago, Illinois, between 1993 and 1996,” Diagnostic Microbiology and Infectious Disease, Vol. 29, No. 4, 1997, pp. 209-214. dio:10.1016/S0732-8893(97)00141-7
[7] A. Pikis, W. J. Rodriguez, J. M. Campos and J. M. Keith, “Optochin-Resistant Streptococcus pneumoniae,” Pediatric Research, Vol. 41, 1997, p. 128. dio:10.1203/00006450-199704001-00775
[8] A. Pikis, J. M. Campos, W. J. Rodriguez and J. M. Keith, “Optochin Resistance in Streptococcus pneumoniae: Mechanism, Significance, and Clinical Implications,” Journal of Infectious Diseases, Vol. 184, No. 5, 2001, pp. 582-590. dio:10.1086/322803
[9] F. Lejbkowicz, M. Goldstein, N. Hashman and L. Cohn, “Optochin-Resistant Streptococcus pneumoniae Isolated from a Blood Specimen,” Clinical Microbiology Newsletter, Vol. 21, No. 9, 1999, pp. 72-73. dio:10.1016/S0196-4399(00)80048-3
[10] S. I. Aguiar, M. J. Frias, L. Santos, J. Melo-Cristino and M. Ramirez, “Emergence of Optochin Resistance among Streptococcus pneumoniae in Portugal,” Microbial Drug Resistance, Vol. 12, No. 4, 2006, pp. 239-245. dio:10.1089/mdr.2006.12.239
[11] S. Nunes, R. Sa-Leao and H. de Lencastre, “Optochin Resistance among Streptococcus pneumoniae Strains Colonizing Healthy Children in Portugal,” Journal of Clinical Microbiology, Vol. 46, No. 1, 2008, pp. 321-324. dio:10.1128/JCM.02097-07
[12] C. A. Dias, G. Agnes, A. P. Frazzon, F. D. Kruger, P. A. d'Azevedo, et al., “Diversity of Mutations in the atpC Gene Coding for the c Subunit of F0F1 ATPase in Clinical Isolates of Optochin-Resistant Streptococcus pneumoniae from Brazil,” Journal of Clinical Microbiology, Vol. 45, No. 9, 2007, pp. 3065-3067. dio:10.1128/JCM.00891-07
[13] P. R. Cortes, A. G. Orio, M. Regueira, G. E. Pinas and J. Echenipue, “Characterization of In Vitro-Generated and Clinical Optochin-Resistant Strains of Streptococcus pneumoniae Isolated from Argentina,” Journal of Clinical Microbiology, Vol. 46, No. 6, 2008, pp. 1930-1934. dio:10.1128/JCM.02318-07
[14] A. Fenoll, R. Munoz, E. García and A. G. de la Campa, “Molecular Basis of the Optochin-Sensitive Phenotype of Pneumococcus: Characterization of the Genes Encoding the F0 Complex of the Streptococcus pneumoniae and Streptococcus oralis H+-ATPases,” Molecular Microbiology, Vol 12, No. 4, 1994, pp. 587-598. dio:10.1111/j.1365-2958.1994.tb01045.x
[15] K. Ubukata, Y. Asahi, A. Yamane and M. Konno, “Combinational Detection of Autolysin and Penicillin-Binding Protein 2B Genes of Streptococcus pneumoniae by PCR,” Journal of Clinical Microbiology, Vol. 34, No. 3, 1996, pp. 592-596.
[16] A. M. Whatmore, A. Efstratiou, A. P. Pickerill, K. Broughton, G. Woodard, D. Sturgeon, et al., “Genetic Relationships between Clinical Isolates of Streptococcus pneumoniae, Streptococcus oralis, and Streptococcus mitis: Characterization of ‘Atypical’ Pneumococci and Organisms Allied to S. mitis Harboring S. pneumoniae Virulence Factor-Encoding Genes,” Infection and Immunity, Vol. 68, No. 3, 2000, pp. 1374-1382. dio:10.1128/IAI.68.3.1374-1382.2000
[17] D. J. Lane, “16S/23S rRNA Sequencing,” In: E. Stackebrandt and M. Goodfellow, Eds., Nucleic Acid Techniques in Bacterial Systematics, Wiley, Chichester, 1991, pp. 115-175.
[18] N. Cogné, J. P. Claverys, F. Denis and C. Martin, “A Novel Mutation in the α-Helix 1 of the c Subunit of the F1/F0 ATPase Responsible for Optochin Resistance of a Streptococcus pneumoniae Clinical Isolate,” Diagnostic Microbiology and Infectious Disease, Vol. 38, No. 2, 2000, pp. 119-121.
[19] R. Munoz, C. G. Dowson, M. Daniels, T. J. Coffey, C. Martin, R. Hakenbeck and B. G. Spratt, “Genetics of Resistance to Third-Generation Cephalosporins in Clinical Isolates of Streptococcus pneumoniae,” Molecular Microbiology, Vol. 6, No. 17, 1992, pp. 2461-2465.
[20] A. Tomas and R. Hotchkiss, “Regulation of the Transformability of Pneumococcal Cultures by Macromolecular Cell Products,” Proceedings of the National Academy of Sciences of the United States of America, Vol. 51, No. 3, 1964, pp. 480-487. dio:10.1073/pnas.51.3.480
[21] Y. Niki, H. Hanaki, T. Matsumoto, M. Yagisawa, S. Kohno, N. Aoki, et al., “Nationwide Surveillance of Bacterial Respiratory Pathogens Conducted by the Japanese Society of Chemotherapy in 2007: General View of the Pathogens’ Antibacterial Susceptibility,” Journal of Infection and Chemotherapy, Vol. 15, No. 3, 2009, pp. 156-167. dio:10.1007/s10156-009-0674-z
[22] A. E. Senior, “The Proton-Translocating ATPase of Escherichia coli,” Annual Review of Biophysics and Biophysical Chemistry, Vol. 19, 1990, pp. 7-41. dio:10.1146/

comments powered by Disqus

Copyright © 2017 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.